Follow
Swati Gupta
Swati Gupta
Alnylam Pharmaceuticals
Verified email at alnylam.com
Title
Cited by
Cited by
Year
Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates
JK Nair, H Attarwala, A Sehgal, Q Wang, K Aluri, X Zhang, M Gao, J Liu, ...
Nucleic acids research 45 (19), 10969-10977, 2017
2152017
Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates
CR Brown, S Gupta, J Qin, T Racie, G He, S Lentini, R Malone, M Yu, ...
Nucleic acids research 48 (21), 11827-11844, 2020
1652020
Reversal of siRNA-mediated gene silencing in vivo
I Zlatev, A Castoreno, CR Brown, J Qin, S Waldron, MK Schlegel, ...
Nature biotechnology 36 (6), 509-511, 2018
742018
MICROBIAL PRODUCTION OF STEVIOL GLYCOSIDES
R Philippe, AP Kumaran, J Donald, K Patel, S Gupta, R Lim, L LI
US Patent App. 15/524,015, 2017
202017
Reverse Transcription Quantitative Polymerase Chain Reaction Methods to Support Pharmacokinetics and Drug Mechanism of Action to Advance Development of RNA Interference …
YX Elena Castellanos-Rizaldos,Christopher R. Brown, Sean Dennin, Joohwan Kim ...
NUCLEIC ACID THERAPEUTICS, 2020
52020
Properties of Parallel Tetramolecular G-Quadruplex Carrying N-Acetylgalactosamine as Potential Enhancer for Oligonucleotide Delivery to Hepatocytes
A Clua, S Grijalvo, N Erande, S Gupta, K Yucius, R Gargallo, S Mazzini, ...
Molecules 27 (12), 3944, 2022
12022
Correction: Clua et al. Properties of Parallel Tetramolecular G-Quadruplex Carrying N-Acetylgalactosamine as Potential Enhancer for Oligonucleotide Delivery to Hepatocytes …
A Clua, S Grijalvo, N Erande, S Gupta, K Yucius, R Gargallo, S Mazzini, ...
Molecules 28 (1), 98, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–7